313 related articles for article (PubMed ID: 23458848)
1. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms and chronic pancreatitis.
Talamini G; Zamboni G; Salvia R; Capelli P; Sartori N; Casetti L; Bovo P; Vaona B; Falconi M; Bassi C; Scarpa A; Vantini I; Pederzoli P
Pancreatology; 2006; 6(6):626-34. PubMed ID: 17135772
[TBL] [Abstract][Full Text] [Related]
3. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
Mandai K; Uno K; Yasuda K
Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
[TBL] [Abstract][Full Text] [Related]
4. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm.
Nakagawa T; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Yagi Y; Yamanaka K; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
Pancreas; 2017 Apr; 46(4):582-588. PubMed ID: 28099253
[TBL] [Abstract][Full Text] [Related]
5. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
6. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
7. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
Choi MG; Kim SW; Han SS; Jang JY; Park YH
Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
[TBL] [Abstract][Full Text] [Related]
8. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
9. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
Okabayashi T; Nishimori I; Maeda H; Hanazaki K
J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
[No Abstract] [Full Text] [Related]
10. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
14. Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS.
Ringold DA; Shroff P; Sikka SK; Ylagan L; Jonnalagadda S; Early DS; Edmundowicz SA; Azar R
Gastrointest Endosc; 2009 Sep; 70(3):488-94. PubMed ID: 19555941
[TBL] [Abstract][Full Text] [Related]
15. Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm.
Kamata K; Takenaka M; Nakai A; Omoto S; Miyata T; Minaga K; Matsuda T; Yamao K; Imai H; Chiba Y; Sakurai T; Watanabe T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kudo M
Oncology; 2017; 93 Suppl 1():102-106. PubMed ID: 29258117
[TBL] [Abstract][Full Text] [Related]
16. Frequency of intraductal papillary mucinous neoplasm in patients with and without pancreas cancer.
Macari M; Eubig J; Robinson E; Megibow A; Newman E; Babb J; Pachter HL; Hajdu C
Pancreatology; 2010; 10(6):734-41. PubMed ID: 21252588
[TBL] [Abstract][Full Text] [Related]
17. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
[TBL] [Abstract][Full Text] [Related]
18. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
19. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
20. Hereditary intraductal papillary mucinous neoplasm of the pancreas.
Denost Q; Chafai N; Arrive L; Mourra N; Paye F
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):e23-5. PubMed ID: 22225963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
